Alfavision Overseas (India) Limited (ALFAVIO.BO)
INR 14.4
(0.84%)
INR 14.4
(0.84%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.35 Billion INR | -13.34% |
| 2022 | 1.56 Billion INR | 9.35% |
| 2021 | 1.43 Billion INR | 161.59% |
| 2020 | 547.23 Million INR | 11.32% |
| 2019 | 491.58 Million INR | 67.77% |
| 2018 | 293.02 Million INR | 19.16% |
| 2017 | 245.9 Million INR | 351.47% |
| 2016 | 54.46 Million INR | 123.33% |
| 2015 | 24.38 Million INR | -44.42% |
| 2014 | 43.87 Million INR | 26.3% |
| 2013 | 34.74 Million INR | 4.49% |
| 2012 | 33.24 Million INR | 75.92% |
| 2011 | 18.9 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.25 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.35 Billion INR | 0.0% |
| 2023 FY | 1.35 Billion INR | -13.34% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 1.56 Billion INR | 9.35% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 1.56 Billion INR | 0.0% |
| 2022 Q2 | 1.3 Billion INR | 0.0% |
| 2021 Q2 | 774.87 Million INR | 0.0% |
| 2021 FY | 1.43 Billion INR | 161.59% |
| 2021 Q4 | 1.43 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 538.67 Million INR | 0.0% |
| 2020 FY | 547.23 Million INR | 11.32% |
| 2020 Q4 | 547.18 Million INR | 0.0% |
| 2019 Q2 | 240.71 Million INR | 0.0% |
| 2019 FY | 491.58 Million INR | 67.77% |
| 2019 Q4 | 491.58 Million INR | 0.0% |
| 2018 Q4 | 293.02 Million INR | 0.0% |
| 2018 Q2 | 252.85 Million INR | 0.0% |
| 2018 FY | 293.02 Million INR | 19.16% |
| 2017 Q3 | 202.22 Million INR | 267.74% |
| 2017 Q2 | 54.99 Million INR | -9.55% |
| 2017 Q1 | 60.79 Million INR | 11.62% |
| 2017 FY | 245.9 Million INR | 351.47% |
| 2017 Q4 | 245.9 Million INR | 21.6% |
| 2016 FY | 54.46 Million INR | 123.33% |
| 2016 Q4 | 54.46 Million INR | -23.42% |
| 2016 Q3 | 71.12 Million INR | 32.74% |
| 2016 Q2 | 53.58 Million INR | 40.44% |
| 2016 Q1 | 38.15 Million INR | 56.43% |
| 2015 Q2 | 39.17 Million INR | -2.44% |
| 2015 FY | 24.38 Million INR | -44.42% |
| 2015 Q1 | 40.14 Million INR | -8.5% |
| 2015 Q4 | 24.38 Million INR | -37.74% |
| 2015 Q3 | 39.17 Million INR | 0.0% |
| 2014 Q1 | 29.13 Million INR | -16.13% |
| 2014 FY | 43.87 Million INR | 26.3% |
| 2014 Q4 | 43.87 Million INR | 42.52% |
| 2014 Q3 | 30.78 Million INR | -13.11% |
| 2014 Q2 | 35.43 Million INR | 21.61% |
| 2013 Q3 | 33.24 Million INR | 0.0% |
| 2013 Q4 | 34.74 Million INR | 4.49% |
| 2013 Q1 | 33.24 Million INR | 0.0% |
| 2013 FY | 34.74 Million INR | 4.49% |
| 2013 Q2 | 33.24 Million INR | 0.0% |
| 2012 FY | 33.24 Million INR | 75.92% |
| 2012 Q4 | 33.24 Million INR | -53.34% |
| 2012 Q3 | 71.25 Million INR | 0.0% |
| 2011 FY | 18.9 Million INR | 0.0% |
| 2011 Q4 | 27.67 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Biocon Limited | 162.76 Billion INR | 99.167% |
| Blue Jet Healthcare Limited | 16.12 Million INR | -8309.74% |
| Concord Biotech Limited | 97.37 Million INR | -1293.044% |
| Dishman Carbogen Amcis Limited | 23.12 Billion INR | 94.134% |
| FERMENTA BIOTECH LIMITED | 1.32 Billion INR | -2.554% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 586.5 Million INR | -131.285% |
| Panacea Biotec Limited | 209.9 Million INR | -546.256% |
| SAMSRITA LABS LIMITED | 22.03 Million INR | -6056.913% |
| Servoteach Industries Limited | 5059.00 INR | -26813321.625% |
| SMS Lifesciences India Limited | 1 Billion INR | -34.674% |
| Supriya Lifescience Limited | 54.88 Million INR | -2371.74% |
| Syngene International Limited | 5.55 Billion INR | 75.568% |
| TAKE Solutions Limited | 370.85 Million INR | -265.779% |
| Titan Biotech Limited | 83.02 Million INR | -1533.756% |
| Transgene Biotek Limited | 140.01 Million INR | -868.853% |
| Vanta Bioscience Limited | 609.53 Million INR | -122.545% |